Generics Industry News Search
 |
|
|
|
|
|
|
March 2012 News Archive |
|
|
| |
|
Perrigo announced that it has initiated market launch and made its first shipments of minoxidil 5% foam...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Glenmark Generics announced they have been granted final approval Ciclopirox Gel and Levonorgestrel & Ethinyl Estradiol Tablets...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
The European Patent Office has upheld a drug patent held by Alnylam Pharmaceuticals, Inc. of Cambridge and the University of Massachusetts Medical School in Worcester in the face of oral opposition in Munich, Germany...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
An Illinois federal judge on Thursday dismissed Pfizer Inc.'s patent infringement suit against Canadian drugmaker Apotex Inc. over a generic version of anti-cholesterol drug Lipitor after the parties announced they had reached a settlement...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Watson Pharmaceuticals, Inc. today confirmed that Watson has launched an authorized generic version of Prometrium (progesterone, USP) capsules, as part of an agreement with Abbott Laboratories...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Teva Pharmaceutical Industries Ltd. announced today the commercial launch of Progesterone capsules, the AB-rated generic equivalent of Abbott Laboratories' Prometrium capsules...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Mylan Inc. today commented on a ruling for partial summary judgment in its patent infringement lawsuit against Sunovion Pharmaceuticals Inc. in relation to Sunovion's Brovana product...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Dr. Reddy's Laboratories announced today that it has launched Ziprasidone hydrochloride capsules, a bioequivalent generic version of Geodon in the US market on March 2, 2012 following the approval by the United States Food & Drug Administration (USFDA) of Dr. Reddy's ANDA for Ziprasidone Hydrochloride Capsules...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Depomed, Inc. today announced it has filed a patent infringement lawsuit in the United States District Court for the District of New Jersey against three companies that have filed Abbreviated New Drug Applications with the FDA to market generic Gralise...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Sun Pharmaceutical Industries Ltd. announced that USFDA has granted an approval for its Abbreviated New Drug Application (ANDA) for generic version of Zyprexa Zydis, Olanzapine ODT...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Merck is trying to improve its place in the cholesterol drug market but its latest attempt faces another hurdle...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
The German subsidiary of Ranbaxy, Basics GmbH located in Leverkusen, today launched Atorvastatin Basics, a generic version of the cholesterol lowering drug Sortis, in the German market...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Ranbaxy announced that the company has launched the generic versions of Atorvastatin tablets, 10mg, 20 mg, 40mg and 80mg in Italy and Sweden and 10mg, 20mg and 40mg in the Netherlands, after receiving approval from the respective local regulatory authorities...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Mylan's patent infringement trial against Sunovion Pharmaceuticals over the bronchitis and emphysema drug Brovana was set for May 21...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Merrill Lynch predicts that Teva will win its patent case to protect Copaxone, its intravenous treatment for multiple sclerosis...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Boca Pharmacal, Inc., today announced that it has received approval from the FDA of its Abbreviated New Drug Application for Methimazole tablets USP...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
AstraZeneca today announced that on 7 March 2012, the FDA denied Citizen Petitions requesting that the FDA withhold finally approving any generic quetiapine product with labelling that omits certain hyperglycaemia warning language that the FDA required AstraZeneca to include in the labelling for Seroquel and Seroquel XR...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
The Food and Drug Administration has approved a version of a drug made by Teva that includes a dose counter, the drug maker said...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
The Hyderabad based Natco Pharma Limited is pleased to announce the granting of a compulsory licence to it, under the provisions of Section 84 of the Indian Patents Act, 1970 for Sorafenib Tosylate...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Biocon and Pfizer today announced the conclusion of their alliance to commercialise Biocon's biosimilar versions of Insulin and Insulin analog products...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
AstraZeneca today filed a lawsuit against the US Food and Drug Administration in the US District Court for the District of Columbia to overturn the FDA's denial on 7 March 2012 of Citizen Petitions filed by AstraZeneca with regard to Seroquel tablets and Seroquel XR extended release tablets...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Teva announced today that it has commenced commercial launch of Escitalopram oxalate tablets...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Forest announced that Forest and Janssen have jointly filed a lawsuit in the U.S. District Court for the District of Delaware against several companies for infringement of U.S. Patent No. 6,545,040...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Alnylam, a leading RNAi therapeutics company, announced today that the United States Patent and Trademark Office has maintained key claims in the company's KSP RNAi patent in interference proceedings...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
United Therapeutics Corporation today announced that it has filed a lawsuit in the U.S. District Court for the District of New Jersey against Sandoz Inc. for infringement of U.S. Patent Nos. 5,153,222, 6,765,117 and 7,999,007 relating to United Therapeutics' product Remodulin injection...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Mylan Pharmaceuticals ULC, the Canadian subsidiary of Mylan Inc., today received approval from Health Canada for Mylan-Rosuvastatin Calcium tablets...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
As the main patent for Viagra, the world's bestselling anti-impotence pill, nears its expiration, Korean pharmaceutical companies are gearing up to push generics into the market...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Watson Pharmaceuticals, Inc. today confirmed that its subsidiary, Watson Laboratories, Inc. Florida, filed an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration (FDA) seeking approval to market Niacin Extended-release tablets...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
The U.S. Food and Drug Administration today approved the first generic versions of Boniva (ibandronate) tablets, a once-monthly product to treat or prevent osteoporosis in women after menopause...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Watson Pharmaceuticals, Inc. today announced that its subsidiary Watson Laboratories, Inc. has received approval from the United States Food and Drug Administration on its Abbreviated New Drug Application for Ibandronate 150mg tablets...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
The Supreme Court unanimously tossed out medical patent claims for Prometheus Laboratories on Tuesday for a test that could help doctors set drug doses for autoimmune diseases like Crohn's disease, a decision that could affect the burgeoning field of personalised medicine...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
AstraZeneca today announced that the High Court in the UK has rendered its opinion on the formulation patent protecting Seroquel XR (quetiapine fumarate) prolonged-release tablets currently pending in the UK court...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Unigene Laboratories, Inc., a leader in the design, delivery, manufacture and development of peptide-based therapeutics today reported that the U.S. Supreme Court denied Apotex's Petition for a Writ of Certiorari on March 19, 2012, in Apotex, Inc., et al. v. Unigene Laboratories, Inc., et al., Supreme Court Docket No. 11-879...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Perrigo Company today announced that it has received a final "Approval for Registration" letter from the Australian Therapeutic Goods Administration permitting the Company to sell generic temozolomide in Australia...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
A potential blockbuster drug produced by Bayer AG and Regeneron Pharmaceuticals Inc. to treat a blindness-causing eye disorder infringes a patent held by Genentech Inc., a U.K. judge ruled...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Sanofi lost an appeals court ruling on its patent-infringement claims against Roche Holding AG's Genentech and Biogen Idec Inc. for the cancer drugs Rituxan and Avastin...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
On 23 March 2012, the US District Court for the District of Columbia issued an opinion and order in AstraZeneca's lawsuit against the US Food and Drug Administration regarding final marketing approval of generic Quetiapine...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Genmab announced today that GlaxoSmithKline has agreed a settlement with Genentech and City of Hope concerning two U.S. patents that relate to recombinant antibody production for Ofatumumab...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Teva has announced the launch of generic Quetiapine film-coated tablets and Quetiapine XL tablets, on day one of patent expiry...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Dr. Reddy's Laboratories announced today that it has launched Quetiapine fumarate tablets (25 mg, 50 mg, 100 mg, 200 mg, 300 mg and 400 mg)...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Mylan today announced that it has received final approval from the U.S. Food and Drug Administration for its Abbreviated New Drug Application for Quetiapine fumarate ablets, 25 mg...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Now that AstraZeneca's Seroquel has gone off-patent, the floodgates have opened in the USA with a number of Indian drugmakers launching their generic versions of the blockbuster antipsychotic...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
It has been one of the most lucrative monopolies of all time, yielding the biotechnology company Amgen roughly $40 billion in sales over 24 years...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Manufacturer of generic pharmaceuticals and active pharmaceutical ingredients Aurobindo Pharma Ltd. announced that the company had obtained final approvals from the US Food & Drug Administration or US FDA to market Quetiapine fumarate tablets...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
AstraZeneca today announced that the US District Court for the District of New Jersey has found the formulation patent protecting Seroquel XR extended release tablets to be valid...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Teva Pharmaceutical Industries Ltd. announces the launch of the authorised generic of Provigil...
|
| |
|
|
Read more >>
|
| |
|
|
|
| |
|
Ranbaxy Pharmaceuticals Canada Inc. (RPCI), a wholly owned subsidiary of Ranbaxy Laboratories Limited, announced that RPCI has received approval from Health Canada to manufacture and market RAN-Rosuvastatin tablets to the Canadian healthcare system...
|
| |
|
|
Read more >>
|
| |
|
|
|
|
|
Contribute
If you would like to contribute or publish your
company press releases at GenericsWeb, please
email us.
|
Home
